Page 123 - Genentech News Today

These five stocks that Cathie Wood's ARK funds own millions of shares of are perfect for aggressive investors who look to get share count leverage on companies that have sizable upside potential.

AC Immune to Present at the BTIG Virtual Biotechnology Conference 2023 Lausanne, Switzerland, July 28, 2023 – AC Immune SA , a clinical-stage biopharmaceutical company pioneering precision medicine...

These companies from various corners of the globe are well positioned for the future.

Operator: Good day, and welcome to the Alexandria Real Estate Equities Second Quarter 2023 Conference Call. All participants will be in listen-only mode.

Operator: Good morning. My name is Ruth and Ill be your conference operator today.

Scientists from the Giulio Superti-Furga Lab at CeMM, the Research Center for Molecular Medicine of the Austrian Academy of Sciences, have developed a new method that allows the discovery of specific inhibitors of a lactate transporter associated with cancer and other disease areas. The compound identified in the assay system could provide a new starting point for cancer treatments. The study has now been published in Cell Chemical Biology.

Basel, 27 July 2023 Excluding COVID-19 products, Group sales increase strongly by 8%1 at constant exchange rates In line with the expected declining demand for COVID-19 products, Group sales...

Reports Second-Quarter Diluted EPS of $1.14 on a GAAP Basis, an Increase of 123.5 Percent; Adjusted Diluted EPS of $2.91, a Decrease of 13.6 Percent; These Results Include an Unfavorable Impact of...

University of Waterloo researchers are working on new drugs which may be the cure for degenerative eye diseases as well as similar issues in other parts of the body.

University of Waterloo researchers are working on new drugs which may be the cure for degenerative eye diseases as well as similar issues in other parts of the body.